ライフサイエンスコーパス: estimated GFR

1 seline urine protein excretion, and baseline estimated GFR.

2 ted with tubulointerstitial fibrosis and low estimated GFR.

3 cause mortality reversed at higher levels of estimated GFR.

4 to be stronger among participants with lower estimated GFR.

5 the range of normal to moderately decreased estimated GFR.

6 hat is not detected with serum creatinine or estimated GFR.

7 the patients were grouped according to their estimated GFR.

8 Similar results were found for decline in estimated GFR.

9 ar disease or diabetes, and lower tertile of estimated GFR.

10 difference between the measured GFR and the estimated GFR.

11 n of an ARB did not alter the decline in the estimated GFR.

12 isease, or a 50% reduction from the baseline estimated GFR.

13 ictors of renal risk that are independent of estimated GFR.

14 ith significantly greater improvement in the estimated GFR.

15 renal function were related to the baseline estimated GFR.

16 at these common SNPs are not associated with estimated GFR.

17 iated with a significantly greater change in estimated GFR (-1.21 mL/min per 1.73 m2 [CI, -2.34 to -0

18 lar events also increased inversely with the estimated GFR: 1.4 (95 percent confidence interval, 1.4

19 cohorts of patients with CKD stages 3 to 5 (estimated GFR, 10-59 mL/min/1.73 m(2)) who were referred

20 bias (median difference between measured and estimated GFR, 2.5 vs. 5.5 mL/min per 1.73 m(2)), improv

21 We randomly assigned 148 patients with estimated GFR=20-45 ml/min per 1.73 m(2) to calcium acet

22 Even moderate renal insufficiency (estimated GFR 30-59cc/min/1.73m(2)) was associated with

23 Patients with ARVD (age 70.7 +/- 7.5 yr; estimated GFR 36 +/- 19 ml/min) had significantly more c

24 d early stage 3 chronic kidney disease (CKD; estimated GFR 45 to 60 ml/min) and followed them longitu

25 severe renal failure at presentation (median estimated GFR 9 ml/min per 1.73 m(2)).

26 was the first occurrence of a change in the estimated GFR (a decline of >/= 30 ml per minute per 1.7

27 otal kidney volume, no overall change in the estimated GFR, a greater decline in the left-ventricular

28 rine sample; and reduced GFR-Cockcroft-Gault estimated GFR (abnormal: <60 ml/min per 1.73 m(2)).

29 The most accurate model included age, sex, estimated GFR, albuminuria, serum calcium, serum phospha

30 e patients, which was not detected by SCr or estimated GFR alone.

31 multaneously, a 10-ml/minute/1.73 m(2) lower estimated GFR (among persons with estimated GFR <60 ml/m

32 Estimated GFR and 24-hr plasma creatinine clearance unde

33 e authors conclude that moderately decreased estimated GFR and albuminuria independently predict card

34 When estimated GFR and albuminuria were examined simultaneous

35 r associations, with the association between estimated GFR and all-cause mortality reversed at higher

36 nt and anti-inflammatory response, increases estimated GFR and decreases BUN, serum phosphorus, and u

37 d association was observed between a reduced estimated GFR and the risk of death, cardiovascular even

38 ed the multivariable association between the estimated GFR and the risks of death, cardiovascular eve

39 than a simpler model that included age, sex, estimated GFR, and albuminuria (integrated discriminatio

40 Cystatin C, estimated GFR, and albuminuria were not associated with

41 y factors (including diabetes, hypertension, estimated GFR, and albuminuria), participants with 25(OH

42 erly adults were categorized on the basis of estimated GFR, and cystatin C (available in 4734 partici

43 he isotope glomerular filtration rate (GFR), estimated GFR, and cystatin C.

44 However, cystatin clearance, estimated GFR, and hemoglobin levels increased significa

45 reatinine ratio, Charlson comorbidity index, estimated GFR, and medication days of insulin were featu

46 defined a rapid decline in cystatin C-based estimated GFR as >3 ml/min per 1.73 m(2)/yr, on the basi

47 ad significant increases in the mean (+/-SD) estimated GFR, as compared with placebo, at 24 weeks (wi

48 ubular atrophy independently associated with estimated GFR at 12 months.

49 The incidence of new kidney scars and the estimated GFR at 24 months did not differ substantially

50 Estimated GFR at baseline was mean 70.4 ml/min/1.73m(2),

51 We estimated GFR at each interval, analyzed changes within

52 between immunohistology scores and age, sex, estimated GFR at entry, or requirement for dialysis.

53 However, the mean estimated GFR at initiation of dialysis in the United St

54 Estimated GFR at LT was the only pretransplantation inde

55 In participants whose estimated GFR based on creatinine was 45 to 74 ml per mi

56 Lower estimated GFR based on cystatin C was strongly associate

57 FR, measuring serum creatinine and reporting estimated GFR based on serum creatinine (eGFRcr) using t

58 Estimated GFR based on serum creatinine is now widely re

59 n after adjustment for age, body mass index, estimated GFR, baseline BP, physical activity, smoking,

60 asured among 807 ARIC participants with CKD (estimated GFR between 15 and 59 ml/min per 1.73 m(2)).

61 with a laboratory finding of CKD (defined as estimated GFR between 15 and 90 ml/min per 1.73 m(2) in

62 age renal disease among participants with an estimated GFR between 30 and 44 mL/min/1.73 m(2) (HR, 1.

63 Estimated GFR, blood pressure, and the urinary albumin-t

64 FR measurement with an exogenous tracer over estimated GFR, but only the British Transplant Society g

65 er minute per 1.73 m2, each reduction of the estimated GFR by 10 units was associated with a hazard r

66 We estimated GFR by mean clearance of creatinine and urea f

67 Estimated GFR by the MDRD4 results declined throughout t

68 res of kidney function were creatinine-based estimated GFR by using the Modification of Diet in Renal

69 Estimated GFR can be highly inaccurate for some patients

70 Similar findings were observed in other estimated GFR categories by the MDRD Study equation.

71 Net reclassification improvement based on estimated GFR categories was significantly positive for

72 orts were reclassified to a higher and lower estimated GFR category, respectively, by the CKD-EPI equ

73 GFR cystatin C in fully adjusted models with estimated GFR creatinine and ACR.

74 nal disease was 6.4% (P < .001) after adding estimated GFR cystatin C in fully adjusted models with e

75 s to localize genes that influence GFR using estimated GFR data from the San Antonio Family Diabetes/

76 progression of CKD, respectively (defined as estimated GFR decline of 0 to 1, 1 to 4, and >4 ml/min p

77 g pre-kidney replacement therapy, an average estimated GFR decline of 4 ml/min/1.73 m(2) per year was

78 In girls post-transplantation, an estimated GFR decline of 4ml/min/1.73m(2) per year pre-k

79 Secondary outcomes included estimated GFR decline, and total kidney volume growth.

80 In contrast, estimated GFR decreased by about 3 ml/min per 1.73 m(2)

81 Estimated GFR decreased early with irbesartan treatment

82 Furthermore, as preadmission estimated GFR decreased, a significant trend of increasi

83 se waves exhibited a notable increase as the estimated GFR decreased, reaching its peak in Group 4 (9

84 ed by the difference of 125I-iothalamate GFR-estimated GFR (delta GFR), and precision was estimated f

85 Associations with estimated GFR demonstrated similar trends.

86 After adjustment for demographics and estimated GFR, each 1-mg/dl increment in serum phosphate

87 ch is safe and effective in patients with an estimated GFR (eGFR) < 45 ml/min per 1.73 m(2) is unknow

88 R >30 mL/min/1.73 m(2), 15 patients (7%) had estimated GFR (eGFR) </=40 mL/min/1.73 m(2) based on the

89 ted of 3834 patients aged 2 to 17 yr with an estimated GFR (eGFR) </=75 ml/min.1.73 m2 enrolled onto

90 en January 2003 and December 2008 who had an estimated GFR (eGFR) <60 ml/min per 1.73 m(2) 30 days af

91 est was CKD at age 60-64 years, suggested by estimated GFR (eGFR) <60 ml/min per 1.73 m(2) and/or uri

92 se mortality among 3093 participants with an estimated GFR (eGFR) <60 ml/min per 1.73 m(2) from the p

93 e defined CKD at follow-up (2005 to 2008) as estimated GFR (eGFR) <60 ml/min per 1.73 m(2); we define

94 Incident CKD was defined as an estimated GFR (eGFR) <60 ml/min per 1.73 m2 at study yea

95 Participants with CKD, defined as an estimated GFR (eGFR) <60 ml/min per 1.73 m2, were furthe

96 thy who had elevated albuminuria and reduced estimated GFR (eGFR) (20 to 75 ml/min per 1.73 m(2)).

97 Moderate CKD was defined as estimated GFR (eGFR) 30 to 59 ml/min per 1.73 m(2).

98 Estimated GFR (eGFR) and albuminuria were followed up to

99 ed to calculate the association of recipient estimated GFR (eGFR) at 1 yr after renal transplantation

100 Mean estimated GFR (eGFR) at the time of pre-emptive transpla

101 We calculated estimated GFR (eGFR) based on serum creatinine measureme

102 It is unknown if low estimated GFR (eGFR) before or early after kidney donati

103 Patients were designated as having CKD when estimated GFR (eGFR) decreased to <60 ml/min per 1.73 m(

104 rch has investigated equations for obtaining estimated GFR (eGFR) from serum creatinine in cross-sect

105 To determine this, we estimated GFR (eGFR) from serum creatinine measurements

106 (51)Cr-EDTA GFR was compared with the estimated GFR (eGFR) from seven published models and our

107 r, it is unclear whether different levels of estimated GFR (eGFR) have the same prognostic significan

108 on between proteinuria and rate of change in estimated GFR (eGFR) in a cohort of 638,150 adults from

109 erular filtration rate (GFR) or albuminuria, estimated GFR (eGFR) is more widely utilized as a marker

110 4743 (23.1% [95% CI, 20.9% to 25.3%]) had an estimated GFR (eGFR) less than 45 mL/min/1.73 m2 and 699

111 rinary albumin-to-creatinine ratio (ACR) and estimated GFR (eGFR) measured at baseline.

112 Patients underwent prospective monitoring of estimated GFR (eGFR) measurements, with assessment of cl

113 d who had demonstrated a slope of decline in estimated GFR (eGFR) of > or =5 ml/min per 1.73 m(2)/yr

114 Participants with an estimated GFR (eGFR) of 15-59 ml/min per 1.73 m(2) at ba

115 Adults (>=18 to <=90 years) with an estimated GFR (eGFR) of 20 mL/min per 1.73 m(2) or great

116 unction and can be combined with predonation estimated GFR (eGFR) or mGFR to predict postdonation kid

117 0.38) levels showed higher correlation with estimated GFR (eGFR) than UAER (r = - 0.23).

118 e primary end point was percentage change in estimated GFR (eGFR) trajectory over the treatment perio

119 ney function was evaluated by cystatin C and estimated GFR (eGFR) using the Modification of Diet in R

120 ,741 people with CKD G3a or G3b defined by 2 estimated GFR (eGFR) values more than 90 days apart were

121 At enrollment, estimated GFR (eGFR) was 51 +/- 21 ml/min per 1.73 m(2)

122 ohort of 416 OLT patients from 1996 to 2009, estimated GFR (eGFR) was assessed during the 12 months b

123 Estimated GFR (eGFR) was calculated for 882 diabetic sib

124 Estimated GFR (eGFR) was calculated using the abbreviate

125 Estimated GFR (eGFR) was calculated using the Chronic Ki

126 Estimated GFR (eGFR) was calculated with the Cockcroft-G

127 the equation in a large, diverse population, estimated GFR (eGFR) was compared to measured GFR (mGFR)

128 Estimated GFR (eGFR) was determined with the Modificatio

129 ure, the associations of different stages of estimated GFR (eGFR) with changes in cardiac structure a

130 is known about the association of changes in estimated GFR (eGFR) with clinical outcomes.

131 seline urine albumin-to-creatinine ratio and estimated GFR (eGFR) with hospitalizations or death with

132 Automated reporting of estimated GFR (eGFR) with serum creatinine measurement i

133 ions was assessed using P(30) (proportion of estimated GFR (eGFR) within 30% of measured GFR (mGFR))

134 ortality outcomes among patients with early [estimated GFR (eGFR)>/=10 ml/min per 1.73 m(2)] versus l

135 An estimated GFR (eGFR)<60 ml/min per 1.73 m2 was present i

136 e risk for ESRD associated with proteinuria, estimated GFR (eGFR), and hematocrit in men who did not

137 h at least one measurement of fasting LDL-C, estimated GFR (eGFR), and proteinuria between 2002 and 2

138 (CCl), Modification of Diet in Renal Disease estimated GFR (eGFR), and serum creatinine (sCr).

139 analyses were conducted of serum creatinine, estimated GFR (eGFR), and urine albumin-creatinine ratio

140 sed risk for adverse outcomes independent of estimated GFR (eGFR), but whether albuminuria also assoc

141 ney function was assessed by albuminuria and estimated GFR (eGFR), calculated by modification of diet

142 iGFR), modification of diet in renal disease estimated GFR (eGFR), Cockcroft-Gault estimated creatini

143 s iothalamate (iGFR) is superior to equation-estimated GFR (eGFR), each of these methods has distinct

144 patitis C seropositivity and albuminuria and estimated GFR (eGFR), respectively, was examined among 1

145 rCl) overestimated I-iothalamate GFR (iGFR), estimated GFR (eGFR), underestimated iGFR, and their ave

146 d total slopes defined by the mean change in estimated GFR (eGFR), where eGFR was estimated from a re

147 GF-23 and PTH were inversely associated with estimated GFR (eGFR), whereas calcitriol levels were lin

148 ar mean age and distribution of preoperative estimated GFR (eGFR).

149 ociate with chronic kidney disease (CKD) and estimated GFR (eGFR).

150 he past 20 years have seen major advances in estimated GFR (eGFR).

151 was categorized by cystatin C quartiles and estimated GFR (eGFR; < to >60 ml/min per 1.73 m(2)), and

152 ference scores (differences between mGFR and estimated GFR [eGFR] or between mGFR and CrCl, or betwee

153 /=3 ml/min per 1.73 m(2) per year decline in estimated GFR [eGFR]), CKD (eGFR < 60 ml/min per 1.73 m(

154 0 participants with CKD stages 2-4 (baseline estimated GFR [eGFR], 44+/-15 ml/min per 1.73 m(2)).

155 Therefore we concentrated on clinical (estimated GFR [eGFR], proteinuria, time posttransplant,

156 Renal function was categorized as estimated GFR (expressed in ml/min per 1.73 m(2)).

157 usted risk of hospitalization with a reduced estimated GFR followed a similar pattern.

158 inine), provides a good approximation to the estimated GFR formula.

159 The primary end point was the change in the estimated GFR from baseline to follow-up, with adjustmen

160 The authors estimated GFR from standardized serum creatinine levels.

161 recipients for early post-HT mortality using estimated GFR from the MDRD and the CKD-EPI equations.

162 At enrolment and 4 years' follow-up we estimated GFR from the plasma clearance of 51Cr-labelled

163 with mild renal insufficiency (defined as an estimated GFR > 55 mL/min per 1.73 m2 but <80 mL/min per

164 en with normal renal function (defined as an estimated GFR > or = 80 mL/min per 1.73 m2).

165 cipants did not have chronic kidney disease (estimated GFR > or =60 mL/min per 1.73 m2) and mean cyst

166 ion of renal replacement therapy (RRT) at an estimated GFR >/=10 ml/min per 1.73 m(2).

167 aged adults were categorized on the basis of estimated GFR >/=90, 60 to 89, and 15 to 59 ml/min per 1

168 n for age, race or ethnicity, and sex, lower estimated GFR (> or =90, 60 to 89, or <60 mL/min per 1.7

169 The outcome was a composite of estimated GFR halving and graft loss.

170 episodes of severe infection (HR, 2.15), and estimated GFR (HR, 0.89) after LT were identified as ind

171 Therefore, we estimated GFR in 18,015 individuals from the IMPROVE-IT

172 ey disease was assessed using cystatin C and estimated GFR in 4637 participants in 1992 to 1993.

173 within these genes for association with the estimated GFR in 74,354 European-ancestry participants f

174 lele was significantly associated with lower estimated GFR in adjusted analyses (P = 0.049), as were

175 of creatinine-based equations to obtain the estimated GFR in adolescents and young adults is poorly

176 were studies that compared measured GFR with estimated GFR in adults using established reference stan

177 ciates with increased fibrosis and decreased estimated GFR in diabetic nephropathy in vivo, perhaps b

178 ethyl was associated with improvement in the estimated GFR in patients with advanced CKD and type 2 d

179 uent elevations of creatinine and decline in estimated GFR in the Cardiovascular Health Study, a comm

180 ely correlated with blood glucose as well as estimated GFR in the donors.

181 Change in estimated GFR in this subgroup over the 11-year period w

182 not significantly associated with change in estimated GFR in women with normal renal function (defin

183 Furthermore, the mean estimated GFR increased from 111.3+/-25.7 to 121.8+/-29.

184 Estimated GFR is a powerful and independent predictor of

185 cal laboratories, and in most circumstances, estimated GFR is sufficient for clinical decision making

186 Over 12 years, 69 patients developed estimated GFR less than 60 mL/min per 1.73 m(2) (16 per

187 The cumulative incidence of estimated GFR less than 60 mL/min per 1.73 m(2) for pati

188 I was greatest among patients with a reduced estimated GFR (less than 45.0 ml per minute per 1.73 m2)

189 dition, the proportions of participants with estimated GFR < 60 ml/min per 1.73 m(2) was 1.5% for non

190 CKD was defined either by an estimated GFR < 60 ml/min per 1.73 m2 or by the presence

191 y albumin/creatinine ratio >/=30 mg/g and/or estimated GFR </=60 ml/min per 1.73 m(2), was present in

192 Patients with severe CKD (estimated GFR <30 ml/min per 1.73 kg/m2) required signif

193 en patients were stratified by CKD stage IV (estimated GFR <30 ml/min per 1.73 m(2)).

194 Those at high risk of CKD progression (eg, estimated GFR <30 mL/min/1.73 m2, albuminuria >=300 mg p

195 We excluded participants with an estimated GFR <45 ml/min per 1.73 m(2) to focus on phosp

196 with heart failure, notably in patients with estimated GFR <50 ml/min per 1.73 m(2).

197 eporting a hip fracture in participants with estimated GFR <60 ml/min (odds ratio [OR] 2.12; 95% conf

198 with and 976 without chronic kidney disease (estimated GFR <60 ml/min per 1.73 m(2)).

199 Only 0.2% of participants had estimated GFR <60 ml/min per 1.73 m(2).

200 CKD was defined as estimated GFR <60 ml/min per 1.73 m(2).

201 als with FH-ESRD were more likely to have an estimated GFR <60 ml/min per 1.73 m(2).

202 CKD was defined as an estimated GFR <60 ml/min per 1.73 m(2).

203 iagnostic codes compared with CKD defined by estimated GFR <60 ml/min per 1.73 m2 were 11 and 96%, re

204 y disease marked by overt proteinuria and/or estimated GFR <60 ml/min per 1.73 m2.

205 um creatinine; prevalence of CKD, defined as estimated GFR <60 ml/min per 1.73 m2; and sensitivity of

206 fness did not associate with CKD (defined by estimated GFR <60 ml/min/1.73 m(2)) in either age- and g

207 on, and the prevalence of CKD stages 3 to 5 (estimated GFR <60 mL/min/1.73 m(2)) was reduced from 8.7

208 atin C or creatinine, and CKD was defined by estimated GFR <60 ml/min/1.73 m(2).

209 m(2) lower estimated GFR (among persons with estimated GFR <60 ml/minute/1.73 m(2)) was associated wi

210 CKD was defined based on estimated GFR <60 mL/minute/1.73m(2) and albuminuria >/=

211 nly among those with chronic kidney disease (estimated GFR, <60 mL/minute/1.73 m(2)): relative differ

212 at lower suPAR levels associated with higher estimated GFR, male sex, and treatment with mycophenolat

213 oups according to their serum creatinine and estimated GFR-MDRD levels: Group 1 (GFR: 60-89), Group 2

214 Estimated GFR, measured annually and estimated using the

215 acrolimus groups, respectively, (n.s.); mean estimated GFR (Nankivell) was 75.3+/-16.6 mL/min and 72.

216 person-years among ARIC participants with an estimated GFR of >/=90, 60 to 89, and 15 to 59 ml/min pe

217 Compared with subjects with estimated GFR of >or=90 ml/min, those with estimated GFR

218 eaths/1000 person-yr among participants with estimated GFR of >or=90, 70 to 89, and <70 ml/min, respe

219 e (dialysis, transplantation, or a sustained estimated GFR of <15 ml per minute per 1.73 m(2)), a dou

220 123 individuals developed CKD, defined by an estimated GFR of <60 ml/min per 1.73 m(2).

221 h estimated GFR of >or=90 ml/min, those with estimated GFR of <70 ml/min exhibited higher relative ri

222 as significantly associated with a change in estimated GFR of -1.69 mL/min per 1.73 m2 (CI, -2.93 to

223 onfidence interval, 1.7 to 1.9), 3.2 with an estimated GFR of 15 to 29 ml per minute per 1.73 m2 (95

224 CKD was defined as an estimated GFR of 15 to 60 ml/min per 1.73 m(2).

225 urface area or 56 to 65 years of age with an estimated GFR of 25 to 44 ml per minute per 1.73 m(2) we

226 ho were either 18 to 55 years of age with an estimated GFR of 25 to 65 ml per minute per 1.73 m(2) of

227 ith a median difference between measured and estimated GFR of 3.9 ml per minute per 1.73 m(2) with th

228 onfidence interval, 1.1 to 1.2), 1.8 with an estimated GFR of 30 to 44 ml per minute per 1.73 m2 (95

229 e level of at least 4.5 mg per deciliter, an estimated GFR of 40.0 to 99.9 ml per minute per 1.73 m(2

230 orrectly reclassified 16.9% of those with an estimated GFR of 45 to 59 ml per minute per 1.73 m(2) as

231 usted hazard ratio for death was 1.2 with an estimated GFR of 45 to 59 ml per minute per 1.73 m2 (95

232 In estimated GFR of 45 to 59 mL/min/1.73 m(2) by the MDRD S

233 , 34.7% of participants were reclassified to estimated GFR of 60 to 89 mL/min/1.73 m(2) by the CKD-EP

234 n 872 outpatients with stable CVD and a mean estimated GFR of 71 ml/min per 1.73 m(2).

235 of 588 (12.7%) individuals had a decline in estimated GFR of at least 3 ml/min per yr per 1.73 m(2).

236 about 33% recovered renal function to above estimated GFR of greater than 60 mL per min.

237 dence interval, 3.1 to 3.4), and 5.9 with an estimated GFR of less than 15 ml per minute per 1.73 m2

238 Chronic kidney disease was defined as an estimated GFR of less than 60 mL/min per 1.73 m2 based o

239 was the first occurrence of a decline in the estimated GFR or ESRD.

240 alysis, 20,806 patients (75.0%) had a normal estimated GFR or stage 1 CKD, 5011 (18.07%) had stage 2

241 patients, 18-60 years of age, with ADPKD and estimated GFR over 50 ml/min/1.73 m(2), in a 1:1 ratio t

242 lted in a slower decline than placebo in the estimated GFR over a 1-year period in patients with late

243 KFC eGFRcys further improved the accuracy of estimated GFR over estimates from either biomarker equat

244 buminuria was associated with higher risk of estimated GFR overall and within every category.

245 lele was significantly associated with lower estimated GFR (P = 0.01) and higher cystatin C (P = 0.00

246 dynamic range, and the best correlation with estimated GFR (R(2) = 0.38 to 0.50, P < 0.01 to 0.001).

247 dinal Study of Adult Men cohort (R=-0.52 for estimated GFR, R=0.22 for urinary albumin-to-creatinine

248 Estimated GFR remained unchanged after the procedure, ir

249 y, mechanical ventilation, and postdischarge estimated GFR (residual kidney function).

250 e approach to discordant GFR measurement and estimated GFR results, the use of method-specific GFR th

251 the assay, cystatin C should be measured and estimated GFR should be calculated and reported using cy

252 a >=300 mg per 24 hours, or rapid decline in estimated GFR) should be promptly referred to a nephrolo

253 Even mild renal disease, as assessed by the estimated GFR, should be considered a major risk factor

254 Adding gait speed to a model that included estimated GFR significantly improved the prediction of 3

255 om 4.6% for those with stage 1 CKD or normal estimated GFR to 9.9% for those with stage 5 CKD (test f

256 The rates of decline in the estimated GFR, urinary albumin excretion, and other seco

257 We estimated GFR using both cystatin C (eGFRcys) and creati

258 We estimated GFR using cystatin C.

259 We estimated GFR using equations that included standardized

260 CHD risk factors and estimated GFR using serum creatinine were measured among

261 Estimated GFR using the CKD-EPI equation is comparable t

262 using the CKD-EPI equation is comparable to estimated GFR using the MDRD equation in risk stratifica

263 he proportion of persons in a data set whose estimated GFR values were within 30% of measured GFR val

264 0 ml per minute per 1.73 m(2) if the initial estimated GFR was >/= 60 ml per minute per 1.73 m(2) or

265 m(2) or a decline of >/= 50% if the initial estimated GFR was <60 ml per minute per 1.73 m(2)), end-

266 The annual change for estimated GFR was -1.71 with metformin and -3.07 ml/min/

267 The change from baseline in the estimated GFR was -2.34 ml per minute per 1.73 m(2) (95%

268 measurement-error adjustment, the change in estimated GFR was -7.72 mL/min per 1.73 m2 (CI, -15.52 t

269 In the intervention group, the decrease in estimated GFR was 0.45 ml/min per 1.73 m(2) per year les

270 -g increase in protein intake; the change in estimated GFR was 1.14 mL/min per 1.73 m2 (CI, -3.63 to

271 The mean estimated GFR was 34 ml/min per 1.73 m(2) (10%-90% range

272 Mean age was 61 years and the mean estimated GFR was 41 ml/min per 1.73 m(2).

273 reatinine clearance was 55 +/- 24 ml/min and estimated GFR was 57 +/- 21 ml/min per 1.73 m(2) at base

274 GFR were greater for all equations when the estimated GFR was 60 mL/min per 1.73 m2 or greater.

275 ge was 68 (+/-10) years, 89% were male, mean estimated GFR was 64 (+/-19) mL/min per 1.73 m(2), and 3

276 ine was 0.9 +/- 0.2 mg/dl, and mean baseline estimated GFR was 90.4 +/- 19.4 ml/min/1.73 m(2).

277 In NHANES, the median estimated GFR was 94.5 mL/min per 1.73 m(2) (IQR, 79.7 t

278 Estimated GFR was an independent predictor of mortality

279 Lower estimated GFR was associated with higher risks of cardio

280 Estimated GFR was calculated from the Modification of Di

281 Estimated GFR was classified into 6 categories (>/=90, 6

282 Mean estimated GFR was consistently higher in the tacrolimus/

283 The rate of change in estimated GFR was similar in the two medication groups,

284 The distribution of estimated GFR was wide and normally shaped, with a mean

285 rum cystatin C, by itself or as a part of an estimated GFR, was a significant predictor of mortality.

286 concentration, creatinine concentration, and estimated GFR were 1.0 mg/L, 79.6 micromol/L (0.9 mg/dL)

287 Serial annual serum creatinine and estimated GFR were also comparable amongst the three gro

288 A antibodies and the measured GFR (mGFR) and estimated GFR were comparable between groups.

289 erum creatinine concentration and changes in estimated GFR were determined.

290 Differences between measured and estimated GFR were greater for all equations when the es

291 Results for estimated GFR were similar.

292 In the first stage, the estimated GFR will remain stable despite the reduction o

293 outcome was the change from baseline in the estimated GFR with bardoxolone methyl, as compared with

294 was 116 (24) (64-160) mL/min per 1.73 m(2), estimated GFR with CKD-EPI was 108 (22) (64-153) mL/min

295 dels were used to explore the association of estimated GFR with incident CVD and all-cause mortality.

296 compare performance of existing equations of estimated GFR with measured GFR of the gold standard; es

297 The percentage of estimated GFR within 30% of measured GFR was similar for

298 3 m(2)), and greater accuracy (percentage of estimated GFR within 30% of measured GFR, 84.1% vs. 80.6

299 This formula yielded 87.7% of estimated GFR within 30% of the iGFR, and 45.6% within 1

300 ration (CKD-EPI) 2021 race-neutral equation, estimated GFR within plus or minus 30% of mGFR for 75% o